Capecitabine or Capecitabine Plus Oxaliplatin vs Fluorouracil Plus Cisplatin as Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial
J. Clin. Oncol 2024 May 06;[EPub Ahead of Print], R Jia, T Shan, A Zheng, Y Zhang, P Lu, G Zhang, F Wang, Z Xu, G Zheng, D Tang, W Zhang, W Li, R Li, Y Guo, L Liu, X Luo, Y Zheng, Z Chang, Q Wang, X Wang, X Yuan, G Kong, S Li, R Yang, D Zhou, J Ren, W Yin, J Li, J Zhang, Z Wang, M Sheng, B Xu, L Li, X Liu, Z Lu, L Wan, F Zhou, S GaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.